PMPRB
-
Director of Canada’s drug price regulator resigns same week as colleague steps downThe executive director of Canada's drug pricing regulator is stepping down days after another member resigned because of concerns the federal government was undermining their work.HealthFeb 24, 2023
-
Member of Canada’s drug pricing regulator quits over ‘lack of support’ for medicine cost reformsA member of the Patented Medicine Prices Review Board has resigned over what he calls a 'lack of support' from the federal government and failure to implement reforms.CanadaFeb 23, 2023
-
Canada again delays overhaul to patented medicine pricing systemMore than three dozen pharmaceutical company executives recently asked Prime Minister Justin Trudeau in a letter for another delay.CanadaJun 29, 2021
![]()
-
Canada battling pharmaceutical companies over new pricing rules, patients caught in the middleCanada wants to prevent medicines from being "excessively priced," making pharma companies question implementation of life-saving drugs here.CanadaDec 9, 2020
![]()
-
Patients, health organizations band together to bring breakthrough treatments to Canada soonerMore than a dozen health organizations and patient groups across Canada have united to call on governments to increase access to life-changing drugs.HealthOct 21, 2020
![]()
